A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazonein Early Parkinson's ...
National Institute of Neurological Disorders and Stroke (NINDS);Michael J. Fox Foundation for Parkinson's Research National Institute of Neurological Disorders and Stroke (NINDS);Michael J. Fox Foundation for Parkin ...